• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AXIOS; PANCREATIC STENT, COVERED, METALLIC, REMOVABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AXIOS; PANCREATIC STENT, COVERED, METALLIC, REMOVABLE Back to Search Results
Model Number M00553640
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Sepsis (2067)
Event Date 06/06/2020
Event Type  Injury  
Manufacturer Narrative
The complainant was unable to provide the suspect device lot number.Therefore, the manufacture and expiration dates are unknown.However, the complainant reported that the device was not expired.Initial reporter city, state and zip code: (b)(6).(b)(4).The complainant indicated that the device was disposed and will not be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation on (b)(6) 2020 that a hot axios stent was successfully implanted in a transgastric position to treat an encapsulated walled-off necrosis (won) with 70% fluid content in the pancreas during a procedure performed on (b)(6) 2020.According to the complainant, on (b)(6) 2020, stent removal procedure was performed.During the procedure, the removal of the stent was attempted 2 to 3 times and it was successfully removed using a snare or forceps.On (b)(6) 2020, the patient experienced sepsis and was given conservative treatment.In the physician's assessment, the physician is not sure if the sepsis and the stent are related.Reportedly, hemostasis was performed once; however, the details were unknown.There is no information available if there was a relationship between the stent and the bleeding.
 
Manufacturer Narrative
Blocks b5 and h6 (patient code) have been updated with additional information received on (b)(6) 2020.Block d4, h4: the complainant was unable to provide the suspect device lot number.Therefore, the manufacture and expiration dates are unknown.However, the complainant reported that the device was not expired.Block e1: initial reporter city, state and zip code: (b)(6) block h6: patient code 2067 captures the reportable event of sepsis.Block h10: the complainant indicated that the device was disposed and will not be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation on (b)(6), 2020 that a hot axios stent was successfully implanted in a transgastric position to treat an encapsulated walled-off necrosis (won) with 70% fluid content in the pancreas during a procedure performed on (b)(6) 2020.According to the complainant, on(b)(6), 2020, stent removal procedure was performed.During the procedure, the removal of the stent was attempted 2 to 3 times and it was successfully removed using a snare or forceps.On (b)(6) 2020, the patient experienced septic sysmptoms and was given conservative treament.In the physician's assessment, the physician is not sure if the sepsis and the stent are related.Reportedly, hemostasis was performed once; however, the details were unknown.There is no information available if there was relationship between the stent and the bleeding.***additional information received on (b)(6) 2020*** according to the complainant, on (b)(6) 2020, moderate bleeding inside the pancreatic cyst was noted.Reportedly, an endoscopic hemostatis was perfomed.In the physician's assessment the bleeding was not related to axios but was caused by a scope procedure.On (b)(6) 2020, a follow-up was performed and sepsis was noted.The patient was reported to be recovering on (b)(6), 2020.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXIOS
Type of Device
PANCREATIC STENT, COVERED, METALLIC, REMOVABLE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
MDR Report Key10235975
MDR Text Key197798208
Report Number3005099803-2020-02626
Device Sequence Number1
Product Code PCU
UDI-Device Identifier08714729904588
UDI-Public08714729904588
Combination Product (y/n)N
PMA/PMN Number
K153088
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 08/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberM00553640
Device Catalogue Number5364
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/11/2020
Initial Date FDA Received07/06/2020
Supplement Dates Manufacturer Received07/21/2020
Supplement Dates FDA Received08/13/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age34 YR
Patient Weight75
-
-